Text Size

Long-Term Follow-Up of Patients Undergoing Catheter Ablation

This study is currently recruiting participants.
Verified March 2011 by University of Oklahoma
Sponsor:
Information provided by:
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT00584558
First received: December 20, 2007
Last updated: March 2, 2011
Last verified: March 2011
History of Changes
  Purpose

The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at the OU Medical Center.


Condition Intervention
Arrhythmia
 Procedure: Catheter Ablation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Long-Term Follow-Up of Patients Undergoing Catheter Ablation

Resource links provided by NLM:

MedlinePlus related topics: Arrhythmia
U.S. FDA Resources

Further study details as provided by University of Oklahoma:

Primary Outcome Measures:
  • Arrhythmia recurrence [ Time Frame: 0-10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Complications [ Time Frame: 0-10 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 5000
Study Start Date: December 2000
Estimated Study Completion Date: November 2050
Estimated Primary Completion Date: November 2050 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Patients undergoing catheter ablation.
 Procedure: Catheter Ablation
Catheter Ablation of arrhythmias
Other Names:
  • All approved ablation catheters
  • Investigational ablation catheters

Detailed Description:

The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at this institution, including recurrence of the ablated arrhythmia and any late complications.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing catheter ablation at the OU Medical Center

Criteria

Inclusion Criteria:

  • Undergoing catheter ablation at the OU Medical Center

Exclusion Criteria:

  • Prisoners
  • Refusal to participate
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00584558

Contacts
Contact: Karen Beckman, MD 405-271-9696 ext 37536 Karen-Beckman@ouhsc.edu

Locations
United States, Oklahoma
OU Medical Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Principal Investigator: Karen Beckman, MD            
Sponsors and Collaborators
University of Oklahoma
Investigators
Principal Investigator: Karen Beckman, MD University of Oklahoma
  More Information

No publications provided

Responsible Party: Karen Beckman, M.D., University of Oklahoma Health Science Center
ClinicalTrials.gov Identifier: NCT00584558     History of Changes
Other Study ID Numbers: 09343
Study First Received: December 20, 2007
Last Updated: March 2, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Oklahoma:
Arrhythmia
Catheter Ablation

Additional relevant MeSH terms:
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013